RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity

Journal of Surgical Research

Volumn 131, Issue 1, 2006, Pages 143-149

  Zhang, Peng Hui ^a   Zou, Lin ^a,b   Tu, Zhi Guang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

c myc; Hepatocellular carcinoma; hTERT; RNA interference

Indexed keywords

ANTIMITOTIC AGENT; MYC PROTEIN; PH1 SHRNA; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL STRAIN HEPG2; CORRELATION ANALYSIS; DNA VECTOR; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; RNA INTERFERENCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSCRIPTION INITIATION; TUMOR CELL; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TELOMERASE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 32444445166     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2005.09.017     Document Type: Article

References (30)

1. T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, T.R. Cech Telomerase catalytic subunit homologs from fission yeast and human Science 277 1997 955
2. C. Cerni Telomeres, telomerase, and myc. An update Mutat. Res. 462 2000 31
3. K. Nagao, M. Tomimatsu, H. Endo, H. Hisatomi, K. Hikiji Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma J. Gastroenterol. 34 1999 83
4. M. Akiyama, O. Yamada, N. Kanda, S. Akita, T. Kawano, T. Ohno, H. Mizoguchi, Y. Eto, K.C. Anderson, H. Yamada Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors Cancer Lett. 178 2002 187
5. K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M.P. Wirth, A. Meye Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin. Cancer Res. 9 2003 3794
6. Q.Y. Du, X.B. Wang, X.J. Chen, W. Zheng, S.Q. Wang Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase World J. Gastroenterol. 9 2003 2030
7. G. Sui, C. Soohoo, B. Affar el, F. Gay, Y. Shi, W.C. Forrester, Y. Shi A DNA vector-based RNAi technology to suppress gene expression in mammalian cells Proc. Natl. Acad. Sci. USA 99 2002 5515
8. T.R. Brummelkamp, R. Bernards, R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550
9. P.H. Zhang, Z.G. Tu, M.Q. Yang, W.F. Huang, L. Zou, Y.L. Zhou Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference Ai Zheng 23 2004 619
10. L.H. Hu, F.H. Chen, Y.R. Li, L. Wang Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer World J. Gastroenterol. 10 2004 3514
11. T. Komata, Y. Kondo, T. Kanzawa, S. Hirohata, S. Koga, H. Sumiyoshi, S.M. Srinivasula, B.P. Barna, I.M. Germano, M. Takakura, M. Inoue, E.S. Alnemri, J.W. Shay, S. Kyo, S. Kondo Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter Cancer Res. 61 2001 5796
12. Z. Geng, D. Zhang, Y. Liu Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene Chin. Med. J. 116 2003 1467
13. A. Latil, D. Vidaud, A. Valeri, G. Fournier, M. Vidaud, R. Lidereau, O. Cussenot, I. Biache hTERT expression correlates with MYC over-expression in human prostate cancer Int. J. Cancer 89 2000 172
14. S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, M. Inoue Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic. Acids Res. 28 2000 669
15. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani Estimating the world cancer burden Globocan 2000 Int. J. Cancer 94 2001 153
16. R. Erlitzki, G.Y. Minuk Telomeres, telomerase and HCC the long and the short of it J. Hepatol. 31 1999 939
17. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806
18. R.X. Lin, C.W. Tuo, Q.J. Lu, W. Zhang, S.Q. Wang Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model Acta. Pharmacol. Sin. 26 2005 762
19. C.J. Chen, S. Kyo, Y.C. Liu, Y.L. Cheng, C.B. Hsieh, D.C. Chan, J.C. Yu, H.J. Harn Modulation of human telomerase reverse transcriptase in hepatocellular carcinoma World J. Gastroenterol. 10 2004 638
20. M.T. Hemann, J.S. Fridman, J.T. Zilfou, E. Hernando, P.J. Paddison, C. Cordon-Cardo, G.J. Hannon, S.W. Lowe An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo Nat. Genet 33 2003 396
21. M. Raponi, G.M. Arndt Double-stranded RNA-mediated gene silencing in fission yeast Nucleic. Acids Res. 31 2003 4481
22. M. Wilda, U. Fuchs, W. Wossmann, A. Borkhardt Killing of leukemic cells with a BCR/ABL fusion gene by, RNA interference (RNAi) Oncogene 21 2002 5716
23. J.M. Jacque, K. Triques, M. Stevenson Modulation of HIV-1 replication by RNA interference Nature 418 2002 435
24. A. Shlomai, Y. Shaul Inhibition of hepatitis B virus expression replication by RNA interference Hepatology 37 2003 764
25. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494
26. H. Hasuwa, K. Kaseda, T. Einarsdottir, M. Okabe Small interfering RNA and gene silencing in transgenic mice and rats FEBS Lett. 532 2002 227
27. V. Kotoula, P. Hytiroglou, A. Pyrpasopoulou, R. Saxena, S.N. Thung, C.S. Papadimitriou Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers Liver 22 2002 57
28. M.A. Casillas, S.L. Brotherton, L.G. Andrews, J.M. Ruppert, T.O. Tollefsbol Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements Gene 316 2003 57
29. L. Zou, P.H. Zhang, C.L. Luo, Z.G. Tu Transcript regulation of human telomerase reverse transcriptase by c-myc and mad1 Acta. Biochim. Biophys. Sin. 37 2005 32
30. R.A. Greenberg, R.C. O'Hagan, H. Deng, Q. Xiao, S.R. Hann, R.R. Adams, S. Lichtsteiner, L. Chin, G.B. Morin, R.A. DePinho Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation Oncogene 18 1999 1219